Twenty-year predictors of peripheral arterial disease compared with coronary heart disease in the scottish heart health extended cohort (SHHEC)

Journal of the American Heart Association

Volumn 6, Issue 9, 2017, Pages

  Tunstall Pedoe, Hugh ^a   Peters, Sanne A E ^b   Woodward, Mark ^a,b,c,d   Struthers, Allan D ^a   Belch, Jill J F ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Cohort study; Coronary heart disease; Epidemiology; Peripheral arterial disease; Risk prediction

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; APOLIPOPROTEIN A; C REACTIVE PROTEIN; CARBON MONOXIDE; CHOLESTEROL; COTININE; CYSTATIN C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; TROPONIN;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR RISK; DEATH; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; SCORING SYSTEM; SCOTLAND; SEX; SMOKING; SOCIAL STATUS; STATISTICS; SURVIVOR; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; FORECASTING; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; PREDICTIVE VALUE; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGE FACTORS; AGED; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SCOTLAND;

EID: 85029772979     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.117.005967     Document Type: Article

References (41)

1. Fowkes FGR, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, Norman PE, Sampson UKA, Williams LJ, Mensah GA, Criqui MH. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382:1329-1340
2. Belch JJF, Topol EJ, Agnelli G, Bertrand M, Califf RM, Clement DL; Prevention of Atherothrombotic Disease Network. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med. 2003;163:884-892
3. Emdin CA, Anderson SG, Callender T, Conrad N, Salimi-Khorshidi G, Mohseni H, Woodward M, Rahimi K. Usual blood pressure, peripheral arterial disease, and vascular risk: cohort study of 4.2 million adults aged 30-90. BMJ. 2015;351:h4865
4. Subherwal S, Patel MR, Kober L, Peterson ED, Bhatt DL, Gislason GH, Olsen AM, Jones WS, Torp-Pedersen C, Fosbol EL. Peripheral arterial disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study. Eur J Prev Cardiol. 2015;22:317-325
5. Pande RL, Perlstein TS, Beckman JA, Creager MA. Secondary prevention and mortality in peripheral arterial disease: National Health and Nutrition Examination Study 1999-2004. Circulation. 2011;124:17-23
6. Cooke JP, Wilson AM. Biomarkers of peripheral arterial disease. J Am Coll Cardiol. 2010;55:2017-2023
7. Shammas NW. Epidemiology, classification, and modifiable risk factors of peripheral arterial disease. Vasc Health Risk Manag. 2007;3:229-234
8. Smith WCS, Crombie IK, Tavendale R, Irving JM, Kenicer MB, Tunstall-Pedoe H. The Scottish Heart Health Study: objectives and development of methods. Health Bull (Edinb). 1987;45:211-217
9. Tunstall-Pedoe H, Woodward M, Tavendale R, A'Brook R, McCluskey MK. Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: cohort study. BMJ. 1997;315:722-729
10. Tunstall-Pedoe H, ed; for the WHO MONICA Project. MONICA Monograph and Multimedia Sourcebook. Geneva, Switzerland: World Health Organization; 2003. Available at: http://apps.who.int/iris/bitstream/10665/42597/1/ 9241562234.pdf. Accessed August 24th 2017
11. Rose G, McCartney P, Reid DD. Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med. 1977;31:42-48
12. Leng GC, Fowkes FG. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological studies. J Clin Epidemiol. 1992;45:1101-1109
13. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. Boston: John Wright; 1982
14. Woodward M, Tunstall-Pedoe H. An iterative technique for identifying smoking deceivers with application to the Scottish Heart Health Study. Prev Med. 1992;21:88-97
15. Woodward M, Brindle P, Tunstall-Pedoe H; for the SIGN group on risk estimation. Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart. 2007;93:172-176
16. Peters SA, Woodward M, Rumley A, Koenig W, Tunstall-Pedoe H, Lowe GD. Direct comparison of three alternative plasma fibrinogen assays with the von Clauss assay in prediction of cardiovascular disease and all-causes mortality: the Scottish Heart Health Extended Cohort. Br J Haematol. 2013;162:392-399
17. Evans A, Salomaa V, Kulathinal S, Asplund K, Cambien F, Ferrario M, Perola M, Peltonen L, Shields D, Tunstall-Pedoe H, Kuulasmaa K; for the MORGAM Project. MORGAM (an international pooling of cardiovascular cohorts). Int J Epidemiol. 2005;34:21-27
18. Zeller T, Hughes M, Tuovinen T, Schillert A, Conrads-Frank A, den Ruijter H, Schnabel RB, Kee F, Salomaa V, Siebert U, Thorand B, Ziegler A, Breek H, Pasterkamp G, Kuulasmaa K, Koenig W, Blankenberg S. BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries. Eur J Epidemiol. 2014;29:777-790
19. Azur MJ, Stuart EQ, Frangakis C, Leaf PJ. Multiple imputation by chained equations: what it is and how does it work? Int J Methods Psychiatr Res. 2011;20:40-49
20. Newsom RB. Comparing the predictive power of survival models using Harrell's C or Somers' D. Stata J. 2010;10:339-358
21. Pencina MJ, Steyerberg EW, D'Agostino RB Sr. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30:11-21
22. Chambless LE, Cummiskey CP, Cui G. Several methods to assess improvement in risk prediction models: extension to survival analysis. Stat Med. 2011;30:22-38
23. Diehm C, Allenberg JR, Pittrow D. Mahn M, Tepohl G, Haberl RL, Daius H, Burghaus I, Trampisch HJ; German Epidemiological Trial on Ankle Brachial Index Study Group. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation. 2009;120:2053-2061
24. Caruana MF, Bradbury AW, Adam DJ. The validity, reliability, reproducibility and extended utility of ankle to brachial pressure index in current vascular surgical practice. Eur J Vasc Endovasc Surg. 2005;29:443-451
25. Alzamora MT, Fores R, Pera G, Baena-Diez JM, Heras A, Sorribes M, Valverde M, Munoz L, Mundet X, Toran P. Incidence of peripheral arterial disease in the ARTPER population cohort after 5 years of follow-up. BMC Cardiovasc Disord. 2016;16:8
26. Belch JJF, McLaren M, Khan F, Hickman A, Muir A, Stonebridge P. The inflammatory process in intermittent claudication. Eur Heart J Suppl. 2002;4 (suppl B):B31-B34
27. Joosten MM, Pai JK, Bertoia ML, Rimm EB, Spiegelman D, Mittleman MA, Mukamal KJ. Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men. JAMA. 2012;308:1660-1667
28. Pande RL, Perlstein TS, Beckman JA, Creager MA. The association of insulin resistance and inflammation with peripheral arterial disease: the National Health and Nutrition Examination Survey 1999-2004. Circulation. 2008;118:33-41
29. Britton KA, Mukamal KJ, Ix JH, Siscovick DS, Newman AB, de Boer IH, Thacker EL, Biggs ML, Gaziano JM, Djousse L. Insulin resistance and incident peripheral artery disease in the Cardiovascular Health Study. Vasc Med. 2012;17:85-93
30. Priest JR, Nead KT, Wehner MR, Cooke JP, Leeper NJ. Self-reported history of childhood smoking is associated with an increased risk for peripheral arterial disease independent of lifetime smoking burden. PLoS One. 2014;9:e88972
31. Korhonen P, Kautiainen H, Aarnio P. Pulse pressure and subclinical peripheral artery disease. J Hum Hypertens. 2014;28:242-245
32. O'Rourke MF, Hashimoto J. Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol. 2007;50:1-13
33. Ix JH, Biggs ML, Kizer JR, Mukamal KJ, Djousse L, Zieman SJ, de Boer IH, Nelson TL, Newman AB, Criqui MH, Siscovick DS. Association of body mass index with peripheral arterial disease in older adults. Am J Epidemiol. 2011;174:1036-1043
34. Gurdasani D, Sjouke B, Tsimikas S, Hovingh GK, Luben RN, Wainwright NWJ, Pomilla C, Wareham NJ, Khaw K-T, Boekholdt SM, Sandhu MS. Lipoprotein (a) and risk of coronary, cerebrovascular and peripheral artery disease; the EPICNorfolk prospective population study. Arterioscler Thromb Vasc Biol. 2012;32:3058-3065
35. Forbang NI, Criqui MH, Allison MA, Ix JH, Steffen BT, Cushman M, Tsai MY. Sex and ethnic differences in the association between lipoprotein (a) and peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis. J Vasc Surg. 2016;63:453-458
36. O'Neill WC, Han KH, Schneider TM, Hennigar RA. Prevalence of nonatheromatous lesions in peripheral arterial disease. Arterioscler Thromb Vasc Biol. 2015;35:439-447
37. Pereira C, Miname MH, Makdisse MR, Watanabe C, Pesaro AE, Jannes CE, Kalil Filho R, Pereira AC, Santos RD. Peripheral arterial disease in heterozygous familial hypercholesterolemia. Atherosclerosis. 2015;242:174-178
38. Tunstall-Pedoe H, Woodward M, Hughes M, Anderson A, Kennedy G, Belch J, Kuulasmaa K; for the MORGAM investigators. Prime mover or fellow traveller: 25-hydroxyvitamin D's seasonal variation, cardiovascular disease and death in the Scottish Heart Health Extended Cohort (SHHEC). Int J Epidemiol. 2015;44:1602-1612
39. Li DM, Zhang Y, Li Q, Xu XH, Ding B, Ma JH. Low 25-hydroxyvitamin D level is associated with peripheral arterial disease in type 2 diabetes patients. Arch Med Res. 2016;47:49-54
40. Nsenqiyumva V, Fernando ME, Moxon JV, Krishna SM, Pinchbeck J, Omer SM, Morris DR, Jones RE, Moran CS, Seto SW, Golledge J. The association of circulating 25-hydroxyvitamin D concentration with peripheral arterial disease: a meta-analysis of observational studies. Atherosclerosis. 2015;243:645-651
41. Igari K, Kudo T, Toyofuku T, Inoue Y. Relationship of inflammatory biomarkers with severity of peripheral arterial disease. Int J Vasc Med. 2016;2016: 6015701